Global NSAIDs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global NSAIDs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the NSAIDs industry chain, the market status of Back Pain Treatment (Aspirin, Ibuprofen), Osteoarthritis Treatment (Aspirin, Ibuprofen), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of NSAIDs.
Regionally, the report analyzes the NSAIDs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global NSAIDs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the NSAIDs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the NSAIDs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., Aspirin, Ibuprofen).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the NSAIDs market.
Regional Analysis: The report involves examining the NSAIDs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the NSAIDs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to NSAIDs:
Company Analysis: Report covers individual NSAIDs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards NSAIDs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Back Pain Treatment, Osteoarthritis Treatment).
Technology Analysis: Report covers specific technologies relevant to NSAIDs. It assesses the current state, advancements, and potential future developments in NSAIDs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the NSAIDs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
NSAIDs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe NSAIDs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of NSAIDs, with price, sales, revenue and global market share of NSAIDs from 2019 to 2024.
Chapter 3, the NSAIDs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the NSAIDs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and NSAIDs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of NSAIDs.
Chapter 14 and 15, to describe NSAIDs sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the NSAIDs industry chain, the market status of Back Pain Treatment (Aspirin, Ibuprofen), Osteoarthritis Treatment (Aspirin, Ibuprofen), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of NSAIDs.
Regionally, the report analyzes the NSAIDs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global NSAIDs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the NSAIDs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the NSAIDs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., Aspirin, Ibuprofen).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the NSAIDs market.
Regional Analysis: The report involves examining the NSAIDs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the NSAIDs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to NSAIDs:
Company Analysis: Report covers individual NSAIDs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards NSAIDs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Back Pain Treatment, Osteoarthritis Treatment).
Technology Analysis: Report covers specific technologies relevant to NSAIDs. It assesses the current state, advancements, and potential future developments in NSAIDs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the NSAIDs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
NSAIDs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Aspirin
- Ibuprofen
- Naproxen
- Nabumetone
- Others
- Back Pain Treatment
- Osteoarthritis Treatment
- Other Disease Treatment
- Bayer
- Novacap
- Abbott
- Pfizer
- Johnson & Johnson
- Cigna
- Geri-Care Pharmaceuticals
- Perrigo Company
- Kopran
- Merck Sharp & Dohme
- Sun Pharmaceutical Industries
- GlaxoSmithKline
- Reddy Pharmaceuticals
- Verywell
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe NSAIDs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of NSAIDs, with price, sales, revenue and global market share of NSAIDs from 2019 to 2024.
Chapter 3, the NSAIDs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the NSAIDs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and NSAIDs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of NSAIDs.
Chapter 14 and 15, to describe NSAIDs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of NSAIDs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global NSAIDs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Aspirin
1.3.3 Ibuprofen
1.3.4 Naproxen
1.3.5 Nabumetone
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global NSAIDs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Back Pain Treatment
1.4.3 Osteoarthritis Treatment
1.4.4 Other Disease Treatment
1.5 Global NSAIDs Market Size & Forecast
1.5.1 Global NSAIDs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global NSAIDs Sales Quantity (2019-2030)
1.5.3 Global NSAIDs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer NSAIDs Product and Services
2.1.4 Bayer NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bayer Recent Developments/Updates
2.2 Novacap
2.2.1 Novacap Details
2.2.2 Novacap Major Business
2.2.3 Novacap NSAIDs Product and Services
2.2.4 Novacap NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novacap Recent Developments/Updates
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott NSAIDs Product and Services
2.3.4 Abbott NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer NSAIDs Product and Services
2.4.4 Pfizer NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson NSAIDs Product and Services
2.5.4 Johnson & Johnson NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 Cigna
2.6.1 Cigna Details
2.6.2 Cigna Major Business
2.6.3 Cigna NSAIDs Product and Services
2.6.4 Cigna NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Cigna Recent Developments/Updates
2.7 Geri-Care Pharmaceuticals
2.7.1 Geri-Care Pharmaceuticals Details
2.7.2 Geri-Care Pharmaceuticals Major Business
2.7.3 Geri-Care Pharmaceuticals NSAIDs Product and Services
2.7.4 Geri-Care Pharmaceuticals NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Geri-Care Pharmaceuticals Recent Developments/Updates
2.8 Perrigo Company
2.8.1 Perrigo Company Details
2.8.2 Perrigo Company Major Business
2.8.3 Perrigo Company NSAIDs Product and Services
2.8.4 Perrigo Company NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Perrigo Company Recent Developments/Updates
2.9 Kopran
2.9.1 Kopran Details
2.9.2 Kopran Major Business
2.9.3 Kopran NSAIDs Product and Services
2.9.4 Kopran NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Kopran Recent Developments/Updates
2.10 Merck Sharp & Dohme
2.10.1 Merck Sharp & Dohme Details
2.10.2 Merck Sharp & Dohme Major Business
2.10.3 Merck Sharp & Dohme NSAIDs Product and Services
2.10.4 Merck Sharp & Dohme NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Merck Sharp & Dohme Recent Developments/Updates
2.11 Sun Pharmaceutical Industries
2.11.1 Sun Pharmaceutical Industries Details
2.11.2 Sun Pharmaceutical Industries Major Business
2.11.3 Sun Pharmaceutical Industries NSAIDs Product and Services
2.11.4 Sun Pharmaceutical Industries NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.12 GlaxoSmithKline
2.12.1 GlaxoSmithKline Details
2.12.2 GlaxoSmithKline Major Business
2.12.3 GlaxoSmithKline NSAIDs Product and Services
2.12.4 GlaxoSmithKline NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 GlaxoSmithKline Recent Developments/Updates
2.13 Reddy Pharmaceuticals
2.13.1 Reddy Pharmaceuticals Details
2.13.2 Reddy Pharmaceuticals Major Business
2.13.3 Reddy Pharmaceuticals NSAIDs Product and Services
2.13.4 Reddy Pharmaceuticals NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Reddy Pharmaceuticals Recent Developments/Updates
2.14 Verywell
2.14.1 Verywell Details
2.14.2 Verywell Major Business
2.14.3 Verywell NSAIDs Product and Services
2.14.4 Verywell NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Verywell Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NSAIDS BY MANUFACTURER
3.1 Global NSAIDs Sales Quantity by Manufacturer (2019-2024)
3.2 Global NSAIDs Revenue by Manufacturer (2019-2024)
3.3 Global NSAIDs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of NSAIDs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 NSAIDs Manufacturer Market Share in 2023
3.4.2 Top 6 NSAIDs Manufacturer Market Share in 2023
3.5 NSAIDs Market: Overall Company Footprint Analysis
3.5.1 NSAIDs Market: Region Footprint
3.5.2 NSAIDs Market: Company Product Type Footprint
3.5.3 NSAIDs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global NSAIDs Market Size by Region
4.1.1 Global NSAIDs Sales Quantity by Region (2019-2030)
4.1.2 Global NSAIDs Consumption Value by Region (2019-2030)
4.1.3 Global NSAIDs Average Price by Region (2019-2030)
4.2 North America NSAIDs Consumption Value (2019-2030)
4.3 Europe NSAIDs Consumption Value (2019-2030)
4.4 Asia-Pacific NSAIDs Consumption Value (2019-2030)
4.5 South America NSAIDs Consumption Value (2019-2030)
4.6 Middle East and Africa NSAIDs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global NSAIDs Sales Quantity by Type (2019-2030)
5.2 Global NSAIDs Consumption Value by Type (2019-2030)
5.3 Global NSAIDs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global NSAIDs Sales Quantity by Application (2019-2030)
6.2 Global NSAIDs Consumption Value by Application (2019-2030)
6.3 Global NSAIDs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America NSAIDs Sales Quantity by Type (2019-2030)
7.2 North America NSAIDs Sales Quantity by Application (2019-2030)
7.3 North America NSAIDs Market Size by Country
7.3.1 North America NSAIDs Sales Quantity by Country (2019-2030)
7.3.2 North America NSAIDs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe NSAIDs Sales Quantity by Type (2019-2030)
8.2 Europe NSAIDs Sales Quantity by Application (2019-2030)
8.3 Europe NSAIDs Market Size by Country
8.3.1 Europe NSAIDs Sales Quantity by Country (2019-2030)
8.3.2 Europe NSAIDs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific NSAIDs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific NSAIDs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific NSAIDs Market Size by Region
9.3.1 Asia-Pacific NSAIDs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific NSAIDs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America NSAIDs Sales Quantity by Type (2019-2030)
10.2 South America NSAIDs Sales Quantity by Application (2019-2030)
10.3 South America NSAIDs Market Size by Country
10.3.1 South America NSAIDs Sales Quantity by Country (2019-2030)
10.3.2 South America NSAIDs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa NSAIDs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa NSAIDs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa NSAIDs Market Size by Country
11.3.1 Middle East & Africa NSAIDs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa NSAIDs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 NSAIDs Market Drivers
12.2 NSAIDs Market Restraints
12.3 NSAIDs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of NSAIDs and Key Manufacturers
13.2 Manufacturing Costs Percentage of NSAIDs
13.3 NSAIDs Production Process
13.4 NSAIDs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 NSAIDs Typical Distributors
14.3 NSAIDs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of NSAIDs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global NSAIDs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Aspirin
1.3.3 Ibuprofen
1.3.4 Naproxen
1.3.5 Nabumetone
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global NSAIDs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Back Pain Treatment
1.4.3 Osteoarthritis Treatment
1.4.4 Other Disease Treatment
1.5 Global NSAIDs Market Size & Forecast
1.5.1 Global NSAIDs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global NSAIDs Sales Quantity (2019-2030)
1.5.3 Global NSAIDs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer NSAIDs Product and Services
2.1.4 Bayer NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bayer Recent Developments/Updates
2.2 Novacap
2.2.1 Novacap Details
2.2.2 Novacap Major Business
2.2.3 Novacap NSAIDs Product and Services
2.2.4 Novacap NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novacap Recent Developments/Updates
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott NSAIDs Product and Services
2.3.4 Abbott NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer NSAIDs Product and Services
2.4.4 Pfizer NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson NSAIDs Product and Services
2.5.4 Johnson & Johnson NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 Cigna
2.6.1 Cigna Details
2.6.2 Cigna Major Business
2.6.3 Cigna NSAIDs Product and Services
2.6.4 Cigna NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Cigna Recent Developments/Updates
2.7 Geri-Care Pharmaceuticals
2.7.1 Geri-Care Pharmaceuticals Details
2.7.2 Geri-Care Pharmaceuticals Major Business
2.7.3 Geri-Care Pharmaceuticals NSAIDs Product and Services
2.7.4 Geri-Care Pharmaceuticals NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Geri-Care Pharmaceuticals Recent Developments/Updates
2.8 Perrigo Company
2.8.1 Perrigo Company Details
2.8.2 Perrigo Company Major Business
2.8.3 Perrigo Company NSAIDs Product and Services
2.8.4 Perrigo Company NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Perrigo Company Recent Developments/Updates
2.9 Kopran
2.9.1 Kopran Details
2.9.2 Kopran Major Business
2.9.3 Kopran NSAIDs Product and Services
2.9.4 Kopran NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Kopran Recent Developments/Updates
2.10 Merck Sharp & Dohme
2.10.1 Merck Sharp & Dohme Details
2.10.2 Merck Sharp & Dohme Major Business
2.10.3 Merck Sharp & Dohme NSAIDs Product and Services
2.10.4 Merck Sharp & Dohme NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Merck Sharp & Dohme Recent Developments/Updates
2.11 Sun Pharmaceutical Industries
2.11.1 Sun Pharmaceutical Industries Details
2.11.2 Sun Pharmaceutical Industries Major Business
2.11.3 Sun Pharmaceutical Industries NSAIDs Product and Services
2.11.4 Sun Pharmaceutical Industries NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.12 GlaxoSmithKline
2.12.1 GlaxoSmithKline Details
2.12.2 GlaxoSmithKline Major Business
2.12.3 GlaxoSmithKline NSAIDs Product and Services
2.12.4 GlaxoSmithKline NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 GlaxoSmithKline Recent Developments/Updates
2.13 Reddy Pharmaceuticals
2.13.1 Reddy Pharmaceuticals Details
2.13.2 Reddy Pharmaceuticals Major Business
2.13.3 Reddy Pharmaceuticals NSAIDs Product and Services
2.13.4 Reddy Pharmaceuticals NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Reddy Pharmaceuticals Recent Developments/Updates
2.14 Verywell
2.14.1 Verywell Details
2.14.2 Verywell Major Business
2.14.3 Verywell NSAIDs Product and Services
2.14.4 Verywell NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Verywell Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NSAIDS BY MANUFACTURER
3.1 Global NSAIDs Sales Quantity by Manufacturer (2019-2024)
3.2 Global NSAIDs Revenue by Manufacturer (2019-2024)
3.3 Global NSAIDs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of NSAIDs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 NSAIDs Manufacturer Market Share in 2023
3.4.2 Top 6 NSAIDs Manufacturer Market Share in 2023
3.5 NSAIDs Market: Overall Company Footprint Analysis
3.5.1 NSAIDs Market: Region Footprint
3.5.2 NSAIDs Market: Company Product Type Footprint
3.5.3 NSAIDs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global NSAIDs Market Size by Region
4.1.1 Global NSAIDs Sales Quantity by Region (2019-2030)
4.1.2 Global NSAIDs Consumption Value by Region (2019-2030)
4.1.3 Global NSAIDs Average Price by Region (2019-2030)
4.2 North America NSAIDs Consumption Value (2019-2030)
4.3 Europe NSAIDs Consumption Value (2019-2030)
4.4 Asia-Pacific NSAIDs Consumption Value (2019-2030)
4.5 South America NSAIDs Consumption Value (2019-2030)
4.6 Middle East and Africa NSAIDs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global NSAIDs Sales Quantity by Type (2019-2030)
5.2 Global NSAIDs Consumption Value by Type (2019-2030)
5.3 Global NSAIDs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global NSAIDs Sales Quantity by Application (2019-2030)
6.2 Global NSAIDs Consumption Value by Application (2019-2030)
6.3 Global NSAIDs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America NSAIDs Sales Quantity by Type (2019-2030)
7.2 North America NSAIDs Sales Quantity by Application (2019-2030)
7.3 North America NSAIDs Market Size by Country
7.3.1 North America NSAIDs Sales Quantity by Country (2019-2030)
7.3.2 North America NSAIDs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe NSAIDs Sales Quantity by Type (2019-2030)
8.2 Europe NSAIDs Sales Quantity by Application (2019-2030)
8.3 Europe NSAIDs Market Size by Country
8.3.1 Europe NSAIDs Sales Quantity by Country (2019-2030)
8.3.2 Europe NSAIDs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific NSAIDs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific NSAIDs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific NSAIDs Market Size by Region
9.3.1 Asia-Pacific NSAIDs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific NSAIDs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America NSAIDs Sales Quantity by Type (2019-2030)
10.2 South America NSAIDs Sales Quantity by Application (2019-2030)
10.3 South America NSAIDs Market Size by Country
10.3.1 South America NSAIDs Sales Quantity by Country (2019-2030)
10.3.2 South America NSAIDs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa NSAIDs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa NSAIDs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa NSAIDs Market Size by Country
11.3.1 Middle East & Africa NSAIDs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa NSAIDs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 NSAIDs Market Drivers
12.2 NSAIDs Market Restraints
12.3 NSAIDs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of NSAIDs and Key Manufacturers
13.2 Manufacturing Costs Percentage of NSAIDs
13.3 NSAIDs Production Process
13.4 NSAIDs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 NSAIDs Typical Distributors
14.3 NSAIDs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global NSAIDs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global NSAIDs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer NSAIDs Product and Services
Table 6. Bayer NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bayer Recent Developments/Updates
Table 8. Novacap Basic Information, Manufacturing Base and Competitors
Table 9. Novacap Major Business
Table 10. Novacap NSAIDs Product and Services
Table 11. Novacap NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novacap Recent Developments/Updates
Table 13. Abbott Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Major Business
Table 15. Abbott NSAIDs Product and Services
Table 16. Abbott NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Abbott Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer NSAIDs Product and Services
Table 21. Pfizer NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson NSAIDs Product and Services
Table 26. Johnson & Johnson NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. Cigna Basic Information, Manufacturing Base and Competitors
Table 29. Cigna Major Business
Table 30. Cigna NSAIDs Product and Services
Table 31. Cigna NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Cigna Recent Developments/Updates
Table 33. Geri-Care Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Geri-Care Pharmaceuticals Major Business
Table 35. Geri-Care Pharmaceuticals NSAIDs Product and Services
Table 36. Geri-Care Pharmaceuticals NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Geri-Care Pharmaceuticals Recent Developments/Updates
Table 38. Perrigo Company Basic Information, Manufacturing Base and Competitors
Table 39. Perrigo Company Major Business
Table 40. Perrigo Company NSAIDs Product and Services
Table 41. Perrigo Company NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Perrigo Company Recent Developments/Updates
Table 43. Kopran Basic Information, Manufacturing Base and Competitors
Table 44. Kopran Major Business
Table 45. Kopran NSAIDs Product and Services
Table 46. Kopran NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Kopran Recent Developments/Updates
Table 48. Merck Sharp & Dohme Basic Information, Manufacturing Base and Competitors
Table 49. Merck Sharp & Dohme Major Business
Table 50. Merck Sharp & Dohme NSAIDs Product and Services
Table 51. Merck Sharp & Dohme NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Merck Sharp & Dohme Recent Developments/Updates
Table 53. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 54. Sun Pharmaceutical Industries Major Business
Table 55. Sun Pharmaceutical Industries NSAIDs Product and Services
Table 56. Sun Pharmaceutical Industries NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Sun Pharmaceutical Industries Recent Developments/Updates
Table 58. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 59. GlaxoSmithKline Major Business
Table 60. GlaxoSmithKline NSAIDs Product and Services
Table 61. GlaxoSmithKline NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. GlaxoSmithKline Recent Developments/Updates
Table 63. Reddy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Reddy Pharmaceuticals Major Business
Table 65. Reddy Pharmaceuticals NSAIDs Product and Services
Table 66. Reddy Pharmaceuticals NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Reddy Pharmaceuticals Recent Developments/Updates
Table 68. Verywell Basic Information, Manufacturing Base and Competitors
Table 69. Verywell Major Business
Table 70. Verywell NSAIDs Product and Services
Table 71. Verywell NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Verywell Recent Developments/Updates
Table 73. Global NSAIDs Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 74. Global NSAIDs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 75. Global NSAIDs Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 76. Market Position of Manufacturers in NSAIDs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 77. Head Office and NSAIDs Production Site of Key Manufacturer
Table 78. NSAIDs Market: Company Product Type Footprint
Table 79. NSAIDs Market: Company Product Application Footprint
Table 80. NSAIDs New Market Entrants and Barriers to Market Entry
Table 81. NSAIDs Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global NSAIDs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 83. Global NSAIDs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 84. Global NSAIDs Consumption Value by Region (2019-2024) & (USD Million)
Table 85. Global NSAIDs Consumption Value by Region (2025-2030) & (USD Million)
Table 86. Global NSAIDs Average Price by Region (2019-2024) & (USD/Pcs)
Table 87. Global NSAIDs Average Price by Region (2025-2030) & (USD/Pcs)
Table 88. Global NSAIDs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 89. Global NSAIDs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 90. Global NSAIDs Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Global NSAIDs Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Global NSAIDs Average Price by Type (2019-2024) & (USD/Pcs)
Table 93. Global NSAIDs Average Price by Type (2025-2030) & (USD/Pcs)
Table 94. Global NSAIDs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 95. Global NSAIDs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 96. Global NSAIDs Consumption Value by Application (2019-2024) & (USD Million)
Table 97. Global NSAIDs Consumption Value by Application (2025-2030) & (USD Million)
Table 98. Global NSAIDs Average Price by Application (2019-2024) & (USD/Pcs)
Table 99. Global NSAIDs Average Price by Application (2025-2030) & (USD/Pcs)
Table 100. North America NSAIDs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 101. North America NSAIDs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 102. North America NSAIDs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 103. North America NSAIDs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 104. North America NSAIDs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 105. North America NSAIDs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 106. North America NSAIDs Consumption Value by Country (2019-2024) & (USD Million)
Table 107. North America NSAIDs Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Europe NSAIDs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 109. Europe NSAIDs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 110. Europe NSAIDs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 111. Europe NSAIDs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 112. Europe NSAIDs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 113. Europe NSAIDs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 114. Europe NSAIDs Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Europe NSAIDs Consumption Value by Country (2025-2030) & (USD Million)
Table 116. Asia-Pacific NSAIDs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 117. Asia-Pacific NSAIDs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 118. Asia-Pacific NSAIDs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 119. Asia-Pacific NSAIDs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 120. Asia-Pacific NSAIDs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 121. Asia-Pacific NSAIDs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 122. Asia-Pacific NSAIDs Consumption Value by Region (2019-2024) & (USD Million)
Table 123. Asia-Pacific NSAIDs Consumption Value by Region (2025-2030) & (USD Million)
Table 124. South America NSAIDs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 125. South America NSAIDs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 126. South America NSAIDs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 127. South America NSAIDs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 128. South America NSAIDs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 129. South America NSAIDs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 130. South America NSAIDs Consumption Value by Country (2019-2024) & (USD Million)
Table 131. South America NSAIDs Consumption Value by Country (2025-2030) & (USD Million)
Table 132. Middle East & Africa NSAIDs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 133. Middle East & Africa NSAIDs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 134. Middle East & Africa NSAIDs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 135. Middle East & Africa NSAIDs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 136. Middle East & Africa NSAIDs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 137. Middle East & Africa NSAIDs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 138. Middle East & Africa NSAIDs Consumption Value by Region (2019-2024) & (USD Million)
Table 139. Middle East & Africa NSAIDs Consumption Value by Region (2025-2030) & (USD Million)
Table 140. NSAIDs Raw Material
Table 141. Key Manufacturers of NSAIDs Raw Materials
Table 142. NSAIDs Typical Distributors
Table 143. NSAIDs Typical Customers
Table 1. Global NSAIDs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global NSAIDs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer NSAIDs Product and Services
Table 6. Bayer NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bayer Recent Developments/Updates
Table 8. Novacap Basic Information, Manufacturing Base and Competitors
Table 9. Novacap Major Business
Table 10. Novacap NSAIDs Product and Services
Table 11. Novacap NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novacap Recent Developments/Updates
Table 13. Abbott Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Major Business
Table 15. Abbott NSAIDs Product and Services
Table 16. Abbott NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Abbott Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer NSAIDs Product and Services
Table 21. Pfizer NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson NSAIDs Product and Services
Table 26. Johnson & Johnson NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. Cigna Basic Information, Manufacturing Base and Competitors
Table 29. Cigna Major Business
Table 30. Cigna NSAIDs Product and Services
Table 31. Cigna NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Cigna Recent Developments/Updates
Table 33. Geri-Care Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Geri-Care Pharmaceuticals Major Business
Table 35. Geri-Care Pharmaceuticals NSAIDs Product and Services
Table 36. Geri-Care Pharmaceuticals NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Geri-Care Pharmaceuticals Recent Developments/Updates
Table 38. Perrigo Company Basic Information, Manufacturing Base and Competitors
Table 39. Perrigo Company Major Business
Table 40. Perrigo Company NSAIDs Product and Services
Table 41. Perrigo Company NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Perrigo Company Recent Developments/Updates
Table 43. Kopran Basic Information, Manufacturing Base and Competitors
Table 44. Kopran Major Business
Table 45. Kopran NSAIDs Product and Services
Table 46. Kopran NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Kopran Recent Developments/Updates
Table 48. Merck Sharp & Dohme Basic Information, Manufacturing Base and Competitors
Table 49. Merck Sharp & Dohme Major Business
Table 50. Merck Sharp & Dohme NSAIDs Product and Services
Table 51. Merck Sharp & Dohme NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Merck Sharp & Dohme Recent Developments/Updates
Table 53. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 54. Sun Pharmaceutical Industries Major Business
Table 55. Sun Pharmaceutical Industries NSAIDs Product and Services
Table 56. Sun Pharmaceutical Industries NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Sun Pharmaceutical Industries Recent Developments/Updates
Table 58. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 59. GlaxoSmithKline Major Business
Table 60. GlaxoSmithKline NSAIDs Product and Services
Table 61. GlaxoSmithKline NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. GlaxoSmithKline Recent Developments/Updates
Table 63. Reddy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Reddy Pharmaceuticals Major Business
Table 65. Reddy Pharmaceuticals NSAIDs Product and Services
Table 66. Reddy Pharmaceuticals NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Reddy Pharmaceuticals Recent Developments/Updates
Table 68. Verywell Basic Information, Manufacturing Base and Competitors
Table 69. Verywell Major Business
Table 70. Verywell NSAIDs Product and Services
Table 71. Verywell NSAIDs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Verywell Recent Developments/Updates
Table 73. Global NSAIDs Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 74. Global NSAIDs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 75. Global NSAIDs Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 76. Market Position of Manufacturers in NSAIDs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 77. Head Office and NSAIDs Production Site of Key Manufacturer
Table 78. NSAIDs Market: Company Product Type Footprint
Table 79. NSAIDs Market: Company Product Application Footprint
Table 80. NSAIDs New Market Entrants and Barriers to Market Entry
Table 81. NSAIDs Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global NSAIDs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 83. Global NSAIDs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 84. Global NSAIDs Consumption Value by Region (2019-2024) & (USD Million)
Table 85. Global NSAIDs Consumption Value by Region (2025-2030) & (USD Million)
Table 86. Global NSAIDs Average Price by Region (2019-2024) & (USD/Pcs)
Table 87. Global NSAIDs Average Price by Region (2025-2030) & (USD/Pcs)
Table 88. Global NSAIDs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 89. Global NSAIDs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 90. Global NSAIDs Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Global NSAIDs Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Global NSAIDs Average Price by Type (2019-2024) & (USD/Pcs)
Table 93. Global NSAIDs Average Price by Type (2025-2030) & (USD/Pcs)
Table 94. Global NSAIDs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 95. Global NSAIDs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 96. Global NSAIDs Consumption Value by Application (2019-2024) & (USD Million)
Table 97. Global NSAIDs Consumption Value by Application (2025-2030) & (USD Million)
Table 98. Global NSAIDs Average Price by Application (2019-2024) & (USD/Pcs)
Table 99. Global NSAIDs Average Price by Application (2025-2030) & (USD/Pcs)
Table 100. North America NSAIDs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 101. North America NSAIDs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 102. North America NSAIDs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 103. North America NSAIDs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 104. North America NSAIDs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 105. North America NSAIDs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 106. North America NSAIDs Consumption Value by Country (2019-2024) & (USD Million)
Table 107. North America NSAIDs Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Europe NSAIDs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 109. Europe NSAIDs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 110. Europe NSAIDs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 111. Europe NSAIDs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 112. Europe NSAIDs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 113. Europe NSAIDs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 114. Europe NSAIDs Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Europe NSAIDs Consumption Value by Country (2025-2030) & (USD Million)
Table 116. Asia-Pacific NSAIDs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 117. Asia-Pacific NSAIDs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 118. Asia-Pacific NSAIDs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 119. Asia-Pacific NSAIDs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 120. Asia-Pacific NSAIDs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 121. Asia-Pacific NSAIDs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 122. Asia-Pacific NSAIDs Consumption Value by Region (2019-2024) & (USD Million)
Table 123. Asia-Pacific NSAIDs Consumption Value by Region (2025-2030) & (USD Million)
Table 124. South America NSAIDs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 125. South America NSAIDs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 126. South America NSAIDs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 127. South America NSAIDs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 128. South America NSAIDs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 129. South America NSAIDs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 130. South America NSAIDs Consumption Value by Country (2019-2024) & (USD Million)
Table 131. South America NSAIDs Consumption Value by Country (2025-2030) & (USD Million)
Table 132. Middle East & Africa NSAIDs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 133. Middle East & Africa NSAIDs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 134. Middle East & Africa NSAIDs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 135. Middle East & Africa NSAIDs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 136. Middle East & Africa NSAIDs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 137. Middle East & Africa NSAIDs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 138. Middle East & Africa NSAIDs Consumption Value by Region (2019-2024) & (USD Million)
Table 139. Middle East & Africa NSAIDs Consumption Value by Region (2025-2030) & (USD Million)
Table 140. NSAIDs Raw Material
Table 141. Key Manufacturers of NSAIDs Raw Materials
Table 142. NSAIDs Typical Distributors
Table 143. NSAIDs Typical Customers
LIST OF FIGURES
Figure 1. NSAIDs Picture
Figure 2. Global NSAIDs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global NSAIDs Consumption Value Market Share by Type in 2023
Figure 4. Aspirin Examples
Figure 5. Ibuprofen Examples
Figure 6. Naproxen Examples
Figure 7. Nabumetone Examples
Figure 8. Others Examples
Figure 9. Global NSAIDs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global NSAIDs Consumption Value Market Share by Application in 2023
Figure 11. Back Pain Treatment Examples
Figure 12. Osteoarthritis Treatment Examples
Figure 13. Other Disease Treatment Examples
Figure 14. Global NSAIDs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global NSAIDs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global NSAIDs Sales Quantity (2019-2030) & (K Pcs)
Figure 17. Global NSAIDs Average Price (2019-2030) & (USD/Pcs)
Figure 18. Global NSAIDs Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global NSAIDs Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of NSAIDs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 NSAIDs Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 NSAIDs Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global NSAIDs Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global NSAIDs Consumption Value Market Share by Region (2019-2030)
Figure 25. North America NSAIDs Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe NSAIDs Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific NSAIDs Consumption Value (2019-2030) & (USD Million)
Figure 28. South America NSAIDs Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa NSAIDs Consumption Value (2019-2030) & (USD Million)
Figure 30. Global NSAIDs Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global NSAIDs Consumption Value Market Share by Type (2019-2030)
Figure 32. Global NSAIDs Average Price by Type (2019-2030) & (USD/Pcs)
Figure 33. Global NSAIDs Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global NSAIDs Consumption Value Market Share by Application (2019-2030)
Figure 35. Global NSAIDs Average Price by Application (2019-2030) & (USD/Pcs)
Figure 36. North America NSAIDs Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America NSAIDs Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America NSAIDs Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America NSAIDs Consumption Value Market Share by Country (2019-2030)
Figure 40. United States NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe NSAIDs Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe NSAIDs Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe NSAIDs Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe NSAIDs Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific NSAIDs Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific NSAIDs Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific NSAIDs Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific NSAIDs Consumption Value Market Share by Region (2019-2030)
Figure 56. China NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America NSAIDs Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America NSAIDs Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America NSAIDs Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America NSAIDs Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa NSAIDs Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa NSAIDs Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa NSAIDs Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa NSAIDs Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. NSAIDs Market Drivers
Figure 77. NSAIDs Market Restraints
Figure 78. NSAIDs Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of NSAIDs in 2023
Figure 81. Manufacturing Process Analysis of NSAIDs
Figure 82. NSAIDs Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. NSAIDs Picture
Figure 2. Global NSAIDs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global NSAIDs Consumption Value Market Share by Type in 2023
Figure 4. Aspirin Examples
Figure 5. Ibuprofen Examples
Figure 6. Naproxen Examples
Figure 7. Nabumetone Examples
Figure 8. Others Examples
Figure 9. Global NSAIDs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global NSAIDs Consumption Value Market Share by Application in 2023
Figure 11. Back Pain Treatment Examples
Figure 12. Osteoarthritis Treatment Examples
Figure 13. Other Disease Treatment Examples
Figure 14. Global NSAIDs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global NSAIDs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global NSAIDs Sales Quantity (2019-2030) & (K Pcs)
Figure 17. Global NSAIDs Average Price (2019-2030) & (USD/Pcs)
Figure 18. Global NSAIDs Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global NSAIDs Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of NSAIDs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 NSAIDs Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 NSAIDs Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global NSAIDs Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global NSAIDs Consumption Value Market Share by Region (2019-2030)
Figure 25. North America NSAIDs Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe NSAIDs Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific NSAIDs Consumption Value (2019-2030) & (USD Million)
Figure 28. South America NSAIDs Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa NSAIDs Consumption Value (2019-2030) & (USD Million)
Figure 30. Global NSAIDs Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global NSAIDs Consumption Value Market Share by Type (2019-2030)
Figure 32. Global NSAIDs Average Price by Type (2019-2030) & (USD/Pcs)
Figure 33. Global NSAIDs Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global NSAIDs Consumption Value Market Share by Application (2019-2030)
Figure 35. Global NSAIDs Average Price by Application (2019-2030) & (USD/Pcs)
Figure 36. North America NSAIDs Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America NSAIDs Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America NSAIDs Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America NSAIDs Consumption Value Market Share by Country (2019-2030)
Figure 40. United States NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe NSAIDs Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe NSAIDs Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe NSAIDs Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe NSAIDs Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific NSAIDs Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific NSAIDs Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific NSAIDs Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific NSAIDs Consumption Value Market Share by Region (2019-2030)
Figure 56. China NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America NSAIDs Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America NSAIDs Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America NSAIDs Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America NSAIDs Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa NSAIDs Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa NSAIDs Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa NSAIDs Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa NSAIDs Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa NSAIDs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. NSAIDs Market Drivers
Figure 77. NSAIDs Market Restraints
Figure 78. NSAIDs Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of NSAIDs in 2023
Figure 81. Manufacturing Process Analysis of NSAIDs
Figure 82. NSAIDs Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
